Collaboration with drug industry won’t affect clinical decisions, says new guideBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2489 (Published 02 April 2012) Cite this as: BMJ 2012;344:e2489
- Clare Dyer
Doctors are being urged not to be “tempted to accept the negative myths about cooperating with industry” in a new guide to promote collaboration between healthcare organisations and the drug industry to improve care of patients in the United Kingdom.
The guidance is supported by organisations representing the industry and by healthcare bodies including the BMA, the Academy of Medical Royal Colleges, and the royal colleges of GPs, physicians, and psychiatrists. The Department of Health for England, the NHS Confederation, and the governments of Scotland and Wales also back the guide, which is aimed at …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.